Patents
Patents for C07D 513 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or (15,120)
09/2007
09/20/2007WO2007081517A8 Anti-viral compounds
09/20/2007US20070219234 Thienopyridine Derivatives
09/20/2007US20070219197 Pyridyl alkene and pyridyl alkine- acid amides as cytostatics and immuno-suppressives
09/20/2007US20070219188 Oxadiazine Derivatives
09/20/2007CA2646235A1 Non-peptidic renin inhibitors nitroderivatives
09/20/2007CA2645711A1 Quinolone derivative or pharmaceutically acceptable salt thereof
09/20/2007CA2643410A1 Substituted imidazo[2,1-b]thiazole compounds and their use for producing drugs
09/19/2007EP1833836A1 Imidazo-fused thiazolo [4,5-b] pyridine based tricyclic compounds and pharmaceutical compositions comprising same
09/19/2007EP1833827A2 Process for preparing 2-methyl-1-(2-methylpropyl)-1h-imidazoý4,5-c¨ý1,5¨naphthyridin-4-amine
09/19/2007EP1833819A1 Pyrazole compounds that modulate the activity of cdk, gsk and aurora kinases
09/19/2007CN101039947A Inhibitors of hcv replication
09/19/2007CN101037445A Imidazo [2,1-b]-1,3,4-thiadiazole derivatives having potential biological activity and synthesizing method thereof
09/19/2007CN100338074C Heterocyclic compounds and cerebral function improvers containing same as active
09/19/2007CN100338073C Substituted phenylacetic acids
09/19/2007CN100338040C Xanthine oxidase inhibitors
09/18/2007US7271184 For controlling parasites on warm-blooded animals; veterinary medicine
09/18/2007US7271173 Mixed kappa/mu opioids and uses thereof
09/18/2007US7271165 Useful for treating or preventing a variety of antibiotic resistant microbial infections; for example, 25-O-deacetyl-25-(2'',3''-dihydroxypropylcarbonoxy)-5'-[4-isobutyl-1-piperazinyl]benzoxazinorifamycin
09/18/2007CA2243234C 5h-thiazolo[3,2-a]pyrimidine derivatives
09/13/2007WO2007053723A3 Process for the preparation of cefdinir
09/13/2007US20070213364 Alkoxyphenylpropanoic Acid Derivatives
09/13/2007US20070213337 Modulators of serotonin receptors
09/13/2007US20070213326 Substituted indole compounds and their use as 5-ht6 receptor modulators
09/13/2007CA2644520A1 Thiadiazole compounds and their use in phototherapy
09/12/2007CN101035795A Thiazolyl-dihydro indazoles
09/11/2007US7268145 Thiobenzimidazole derivatives
09/07/2007WO2007009963A1 Substituted amides, their preparation and their use as pharmaceuticals
09/06/2007US20070208166 Tao Kinase Modulators And Method Of Use
09/06/2007US20070208049 e.g. 1-(2,6-Difluorobenzyl)-5-(3-Mehthoxyphenyl)-6-Methyl-3-[N-Methyl -N -(2-Pyridylethyl)Aminoethyl]Uracil; anticarcinoganic agent; prostate cancer, benign prostatic hypertrophy, breast cancer and endometriosis
09/05/2007EP1828209A2 Sulfonamido-macrocycles as tie2 inhibitors
09/05/2007EP1828208A2 Crystalline form of cefdinir cesium salt
09/05/2007EP1828207A1 Thiazolopyridinone derivates as mch receptor antagonists
09/05/2007EP1828200A1 Bi- and tricyclic substituted phenyl methanones as glycine transporter i (glyt-1) inhibitors for the treatment of alzheimer's disease.
09/05/2007EP1828181A2 Pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2m3-b]pyrimidin-4-yl-amines as janus kinase inhibitors
09/04/2007US7265128 3-amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
08/2007
08/30/2007WO2006113837A3 Inhibitors of akt activity
08/30/2007US20070203343 Cyanine Dye Labelling Reagents
08/30/2007US20070203189 having proinflammatory cytokine production inhibiting properties, in particular tumor necrosis factor-alpha (TNF-alpha) and/or interleukin-12 (IL-12) inhibiting properties, used for the prevention or the treatment of inflammatory and/or autoimmune diseases
08/30/2007US20070203179 Azadecalin Glucocorticoid Receptor Modulators
08/30/2007US20070203135 angiogenesis inhibitors; as antitumor agents; kinase inhibitors like vascular endothelial growth factor receptors antagonists
08/30/2007US20070203101 Pyrazolyl-substituted heterocycles and their use as phytosanitary products
08/29/2007EP1643998B1 Dual nk1/nk3 antagonists for treating schizophrenia
08/29/2007CN101027309A Enantiomers of selected fused pyrimidones and uses in the treatment and prevention of cancer
08/29/2007CN101027295A Chemical compounds and pharmaceutical compositions containing them for the treatment of inflammatory disorders
08/29/2007CN100334093C Thienopyrimidinediones and their use in the modulation of autoimmune disease
08/28/2007US7262302 Antiinflammatory action; rheumatoid arthritis
08/28/2007US7262211 Activity as non-covalent inhibitors of urokinase and having activity in reducing or inhibiting blood vessel formation are provided. These compounds have at a group having a guanidino moiety or derivative thereof. These compounds are useful for
08/28/2007US7262204 Modulation of CCR4 function
08/28/2007US7262190 Benzothiazine and benzothiadiazine compounds
08/28/2007US7262189 Cognition activators; neurodegenerative diseases; anxiolytic agents;psychological disorders; alzheimer's disease; Huntington's disease; antiischemic agents; antiepileptic agenst
08/28/2007US7262187 Substituted oxazolo- and thizaolopyrimidinones as a mitotic kinesin inhibitor
08/23/2007WO2007095423A1 Bicyclic imidazole or thiadiazole heterocycles useful as selective androgen receptor modulators
08/23/2007WO2007093963A1 Ethanol or 1,2-ethanediol cyclohexyl antibiotic derivatives
08/23/2007WO2007093541A1 Heterocyclic antiviral compounds
08/23/2007WO2007015866A3 Inhibitors of p38 kinase and methods of treating inflammatory disorders
08/23/2007US20070197500 3-(2,3-Dihydro-1'H-spiro[indene-1,4'-piperidin]-1'-yl)-N,N-dimethyl-2-(pyridin-2-ylmethyl)propanamide; opioid receptor-like 1 antagonist; reduced inhibitory activity at HERG potassium channel; analgesic; side effect reduction; neurpathic and other pain
08/23/2007CA2642483A1 Heterocyclic antiviral compounds
08/23/2007CA2642205A1 Bicyclic imidazole or thiadiazole heterocycles useful as selective androgen receptor modulators
08/23/2007CA2635205A1 Ethanol or 1,2-ethanediol cyclohexyl antibiotic derivatives
08/22/2007EP1359908B1 Quinolines and nitrogenated derivatives thereof substituted in 4-position by a piperidine-containing moiety and their use as antibacterial agents
08/22/2007CN1332961C Inhibitors of alpha L beta 2 mediated cell adhesion
08/22/2007CN101023086A Selected fused heterocyclics and uses thereof
08/22/2007CN101023082A Fused pyrimidones useful in the treatment and the prevention of cancer
08/21/2007US7259261 Racemization and enantiomer separation of clopidogrel
08/16/2007WO2007091570A1 Binding inhibitor of sphingosine-1-phosphate
08/16/2007WO2007053722A9 Crystalline form of cefdinir cesium salt
08/16/2007WO2007041365B1 3-cyclyl-2- (4-sulfamo yl-phenyl) -n-cyclyl-propionamide derivatives useful in the treatment of impaired glucose tolerance and diabetes
08/16/2007WO2006074046A3 Process for preparing 2-methyl-1-(2-methylpropyl)-1h-imidazo[4,5-c][1,5]naphthyridin-4-amine
08/16/2007US20070191337 Annellated carbamyl-aza-heterocyclic compounds, a focused library, pharmaceutical compositions, and methods of preparing the same
08/15/2007EP1480640B1 Peroxisome proliferator activated receptor modulators
08/15/2007EP1377590B1 Thiazolopyrimidine derivatives and use thereof as antagonists of the cx3cr1 receptor
08/15/2007CN101016306A Synthesis of middle position-tetraphenyldiphenanthrene disulphoporphyrin derivative and application thereof
08/14/2007US7256293 Imidazopyridine intermediates
08/14/2007US7256187 E.g., 11-Dideoxy-4,11-dihydroxyiminorifamycin S and (R/S)-3-[4-(3-Carboxy-1-cyclopropyl-6-fluoro-8-methoxy-4-oxo-1,4-dihydroquinolin-7-yl)-2-methyl-piperazin-1-yl-aminomethylenyl]-11-deoxy-11-hydroxyiminorifamycin SV; especially effective against rifamycin-resistant microbes
08/09/2007WO2007089667A1 Compounds and compositions as ppar modulators
08/09/2007WO2007089512A1 Glucokinase activators
08/09/2007WO2007089310A1 Bipartite inhibitors of bacterial rna polymerase
08/09/2007WO2007087716A1 Assay for identifying inhibitors of neuronal apoptotic pathways
08/09/2007US20070185325 2,4-dioxopyrimidine-based mesoionic pigments
08/09/2007US20070185207 Indol-7 sulfonamide derivatives, their preparation and their use 5-ht-6 as modulators
08/09/2007US20070185158 Indol-4 sulfonamide derivatives, their preparation and their use 5-ht-6 as modulators
08/09/2007US20070185112 Piperidine/piperazine-type inhibitors of p38 kinase
08/09/2007US20070185089 Benzazepine derivatives for the treatment of neurological and psychiatric disorders
08/09/2007US20070185087 Compounds and methods for inhibiting mitotic progression
08/09/2007US20070185007 Inhibition of HiV integrase compounds
08/09/2007CA2637172A1 Pyridin-2-amine derivatives and their use as glucokinase activators
08/09/2007CA2627644A1 Compounds and compositions as ppar modulators
08/08/2007EP1816127A1 Triazine derivatives for use as selective npy (y5) antagonists
08/08/2007EP1611121B1 Pyridazinone derivatives as cdk2-inhibitors
08/08/2007CN1330657C Novel piperidine and piperazine derivatives
08/08/2007CN101014603A Compounds and methods for inhibiting mitotic progression by ingibiting aurora kinase
08/08/2007CN101014598A Aminocyclohexanes as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
08/08/2007CN101014580A Morpholine compound
08/08/2007CN101014573A 5-HT7 receptor antagonists
08/07/2007US7253196 Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1
08/07/2007US7253188 Aminobenzamide derivative
08/07/2007US7253163 Benzothiazine and benzothiadiazine compounds
08/07/2007US7253162 Alzheimer's disease; cognition activators; central nervous system disorders
08/07/2007US7253161 Cognition activators; neurodegenerative disease; anxiolytic agents; Alzheimer's diseas; Pick's disease; schizophrenia; psychological disorders; antiischemic agents; antiepileptic agents; antidepressants
08/07/2007US7253154 Substituted thiazolopyrimidines as xanthine oxidase inhibitors
1 ... 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 ... 152